Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 161

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 5
Chunk 161
---
 2024.  Refer to “—Results of Operations” for further discussion of the year-over-year changes in net earnings and diluted net earnings per common share for the years ended December 31, 2024 and 2023.  In response to current economic conditions, the Company expects to review and adjust its cost structure.  In the first quarter of 2025, the Company commenced an initiative to identify productivity improvement and cost savings opportunities that we anticipate would generate annual pre-tax savings of at least $150 million.  The Company expects these opportunities to be broad-based, including opportunities within China and the Diagnostics segment.

Acquisitions 

During 2024, the Company acquired 3 businesses for total consideration of $558 million in cash, net of cash acquired.  The businesses acquired complement existing units of the Company’s Life Sciences segment.  The Company preliminarily recorded an aggregate of $305 million of goodwill related to these acquisitions.  

Refer to Note 2 to the Consolidated Financial Statements for discussion regarding the Company’s acquisitions. 

Veralto Corporation Separation

On September 30, 2023 (the “Distribution Date”), the Company completed the separation (the “Separation”) of its former Environmental & Applied Solutions business by distributing to Danaher stockholders on a pro rata basis all of the issued and outstanding common stock of Veralto Corporation (“Veralto”), the entity Danaher incorporated to hold such businesses.  To effect the Separation, Danaher distributed to its stockholders one share of Veralto common stock for every three shares of Danaher common stock outstanding as of September 13, 2023, the record date for the distribution.  Fractional shares of Veralto common stock that otherwise would have been distributed were aggregated and sold into the public market and the proceeds distributed to Danaher stockholders who otherwise would have received fractional shares of Veralto common stock.

The accounting requirements for reporting the Separation as a discontinued operation were met when the Separation was completed.  Refer to Note 3 to the Consolidated Financial Statements for further discussion.  

RESULTS OF OPERATIONS

In this report, references to the non-GAAP measure of core sales (also referred to as core revenues or sales/revenues from existing businesses) refer to sales from continuing operations calculated according to generally accepted accounting principles in the United States (“GAAP”) but excluding:

•sales from acquired businesses (as defined below); and

•the impact of currency translation.

References to sales